Welcome to LookChem.com Sign In|Join Free
  • or
5-BROMO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

405142-63-4

Post Buying Request

405142-63-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

405142-63-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 405142-63-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,1,4 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 405142-63:
(8*4)+(7*0)+(6*5)+(5*1)+(4*4)+(3*2)+(2*6)+(1*3)=104
104 % 10 = 4
So 405142-63-4 is a valid CAS Registry Number.

405142-63-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromo-1,2,3,4-tetrahydro-naphthalen-1-ylamine

1.2 Other means of identification

Product number -
Other names 5-BROMO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:405142-63-4 SDS

405142-63-4Upstream product

405142-63-4Downstream Products

405142-63-4Relevant academic research and scientific papers

MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF

-

Paragraph 0541; 0559, (2021/01/23)

The disclosure relates to compounds and pharmaceutical compositions capable of modulating the hydroxysteroid 17-beta dehydrogenase (HSD17B) family member proteins including inhibiting the HSD17B member proteins, e.g. HSD17B13. The disclosure further relates to methods of treating liver diseases, disorders, or conditions with the compounds and pharmaceutical compositions disclosed herein, in which the HSD17B family member protein plays a role.

SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS

-

Page/Page column 38, (2008/12/04)

Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 405142-63-4